Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment) (DG47)Product type:GuidanceProgramme:Diagnostics guidancePublished: 30 March 2022
MMprofiler for prognostic risk classification in multiple myeloma (MT623) (MIB270)Status:Topic selectionProgramme:Diagnostics guidanceExpected publication date: TBC